Canadian biopesticide firm gets boost from Bayer

MustGrow Biologics, a Canadian-based agricultural biotech company, could make a big leap. This, after reaching an agreement with the German pharmaceutical company Bayer so that it evaluates its biological technologies to determine the efficacy and its commercial potential in key agricultural regions such as Europe, Asia-Pacific, the Middle East and Africa.

According to a MustGrow press release, the Canadian granted Bayer the right to use the company's intellectual property for testing purposes and the option to acquire exclusive rights to its technologies for pre-plant soil fumigation, of bioherbicides and post-harvest preservation of potatoes, including sprout inhibition in regions of Europe, Asia Pacific, Middle East and Africa.

Under the agreement, Bayer will fund and drive all laboratory, field development, regulatory work and market development necessary for commercialization. MustGrow will continue to conduct field testing, R&D and regulatory development simultaneously in other regions, collaborating with numerous consumer food, chemical and agricultural companies.

MustGrow's line of technology focuses on safe, effective and organic plant-based biopesticides that harness the natural defense mechanism of the mustard seed to treat diseases, pests and weeds. The company's technology has demonstrated consistent efficacy in many regions of North and South America, on multiple crops, covering many pests, for several years.

“We are thrilled to accelerate the development and understanding of our technology with Bayer in these important food-producing regions”, says Corey Giasson, CEO of MustGrow. “I am hopeful that we potentially have a sustainable solution for farmers to help with key issues in their production of food.” 

SUBSCRIBE TO OUR NEWSLETTER

Suscríbete a nuestro newsletter